Form 4 for OFIX Orthofix Medical Inc.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-09 · accession 0001193125-26-011929 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-13 | 2026-01-09+ | OFIX | Calafiore Massimo | Pres, CEO, Dir | S - Sale | $15.51 | -19.4K | 217.2K | -8% | -$300.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-09 | S | D | 9,600 | $15.82 | 227,034 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.57 to $16.15, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4. (F3) Includes 135,369 previously reported deferred stock units and an aggregate of 2,031 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2025. |
| 2 | Common | Common Stock | 2026-01-12 | S | D | 9,797 | $15.21 | 217,237 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.02 to $15.75, inclusive. (F3) Includes 135,369 previously reported deferred stock units and an aggregate of 2,031 shares acquired under Orthofix's Stock Purchase Plan on 10/31/2025. |